Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNE1 | P15382 | 8/20 | 0.54 |
| ▸ | KCNQ1 | P51787 | 8/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 5/20 | 0.40 |
| ▸ | MAOA | P21397 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6605946 | 0.87 | KCNE1 (0.55) | KCNE1KCNQ1KCNH2KDM4EMEN1 | |
| SCHEMBL6603457 | 0.80 | KCNE1 (0.66) | KCNE1KCNQ1KCNH2MAOBMAOA | |
| SCHEMBL6601023 | 0.80 | KCNE1 (0.53) | KCNE1KCNQ1KCNH2MEN1KMT2A | |
| SCHEMBL6600267 | 0.80 | KCNE1 (0.48) | KCNE1KCNQ1KCNH2KDM4EMEN1 | |
| SCHEMBL6602375 | 0.79 | KCNE1 (0.49) | KCNE1KCNQ1KCNH2KDM4EMEN1 | |
| SCHEMBL6600820 | 0.78 | KCNE1 (0.47) | KCNE1KCNQ1KCNH2KDM4EMEN1 | |
| SCHEMBL8479947 | 0.78 | KCNE1 (0.52) | KCNE1KCNQ1KCNH2KDM4EMEN1 | |
| SCHEMBL6559307 | 0.78 | KCNE1 (0.59) | KCNE1KCNQ1KCNH2MAOBMEN1 | |
| SCHEMBL7910176 | 0.78 | KCNE1 (0.47) | KCNE1KCNQ1KCNH2KDM4EMEN1 | |
| SCHEMBL6602327 | 0.78 | KCNE1 (0.48) | KCNE1KCNQ1KCNH2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0906911-B1 | Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them | AVENTIS PHARMA GMBH (DE) | 2004-04-28 | — | — | EP | disclosed |
| US-6177449-B1 | CARDIOVASCULAR DISORDERS; ANTIULCER AGENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-01-23 | — | — | US | disclosed |
| EP-0906911-A1 | Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them | Hoechst Marion Roussel Deutschland GmbH (DE) | 1999-04-07 | — | — | EP | disclosed |